SlateStone Wealth’s Gilead Sciences GILD Stock Holding History

SlateStone Wealth’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,789	Closed	-$220K	–	297
2025 Q4	$220K	Buy	+1,789	New	+$217K	0.02%	281
2025 Q2	–	Sell	-1,789	Closed	-$200K	–	296
2025 Q1	$200K	Sell	1,789 -780	-30%	-$80.5K	0.02%	273
2024 Q4	$237K	Buy	+2,569	New	+$231K	0.02%	262
2024 Q1	–	Sell	-11,377	Closed	-$922K	–	286
2023 Q4	$922K	Sell	11,377 -891	-7%	-$69.3K	0.12%	125
2023 Q3	$919K	Buy	12,268 +1,185	+11%	+$91.1K	0.13%	119
2023 Q2	$854K	Sell	11,083 -536	-5%	-$42.7K	0.16%	98
2023 Q1	$964K	Buy	11,619 +3,031	+35%	+$251K	0.2%	95
2022 Q4	$737K	Buy	8,588 +480	+6%	+$38K	0.18%	93
2022 Q3	$500K	Buy	8,108 +1,847	+30%	+$116K	0.13%	113
2022 Q2	$387K	Buy	6,261 +2,651	+73%	+$164K	0.1%	127
2022 Q1	$215K	Buy	+3,610	New	+$231K	0.05%	169

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

SlateStone Wealth's GILD Position: Q1 2026 in Review

SlateStone Wealth sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 1,789 shares — an estimated $220K sold.

SlateStone Wealth first reported a position in GILD in Q1 2022 and held it in 11 quarters. The position peaked at $964K in Q1 2023. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

SlateStone Wealth reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
SlateStone Wealth sold 1,789 Gilead Sciences shares in Q1 2026, an estimated $220K.
SlateStone Wealth first reported a position in Gilead Sciences in Q1 2022 and held it in 11 quarters.
SlateStone Wealth's Gilead Sciences position peaked at $964K in Q1 2023.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on SlateStone Wealth's 13F filing for Q1 2026, filed 14 May 2026.